Statement Of Changes In Equity [Abstract]

Captor Therapeutics S.A. - Filing #6179999

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
96 322 PLN
175,000 PLN
170 031 PLN
19 785 PLN
94 102 PLN
417,000 PLN
16,000 PLN
96 322 PLN
11 779 PLN
11,000 PLN
124 201 PLN
58 208 PLN
170 031 PLN
413,000 PLN
124 201 PLN
175,000 PLN
58 208 PLN
175,000 PLN
124 201 PLN
11,000 PLN
124 201 PLN
170 031 PLN
413,000 PLN
11 779 PLN
7,000 PLN
359,000 PLN
1 004 PLN
25 636 PLN
5 690 PLN
16 292 PLN
1 004 PLN
2 284 PLN
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
35 894 PLN
35 894 PLN
35 894 PLN
32 572 PLN
32 572 PLN
32 572 PLN
Other comprehensive income
5,000 PLN
5,000 PLN
5,000 PLN
38,000 PLN
42,000 PLN
4,000 PLN
42,000 PLN
Comprehensive income
35 889 PLN
35 894 PLN
35 889 PLN
5,000 PLN
38,000 PLN
32 530 PLN
4,000 PLN
32 530 PLN
32 572 PLN
Issue of equity
4,000 PLN
4,000 PLN
4,000 PLN
5 601 PLN
148 240 PLN
153 739 PLN
102,000 PLN
148 240 PLN
Increase (decrease) through share-based payment transactions, equity
8 006 PLN
8 006 PLN
8 006 PLN
9 495 PLN
9 495 PLN
9 495 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.